tiprankstipranks
Trending News
More News >
Basilea Pharmaceutica (CH:BSLN)
:BSLN
Switzerland Market

Basilea Pharmaceutica (BSLN) Technical Analysis

Compare
7 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Basilea Pharmaceutica’s (BSLN) Moving Averages Convergence Divergence (MACD) indicator is 0.64, suggesting Basilea Pharmaceutica is a Buy.
Basilea Pharmaceutica’s (BSLN) 20-Day exponential moving average is 54.69, while Basilea Pharmaceutica’s (BSLN) share price is CHF56.5, making it a Buy.
Basilea Pharmaceutica’s (BSLN) 50-Day exponential moving average is 53.04, while Basilea Pharmaceutica’s (BSLN) share price is CHF56.5, making it a Buy.

Basilea Pharmaceutica (BSLN) Pivot Points

Feb 05, 2026, 05:25 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
52.53
53.07
53.93
54.47
55.33
55.87
56.73
Fibonacci
53.07
53.60
53.93
54.47
55.00
55.33
55.87
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Basilea Pharmaceutica (BSLN) Moving Averages

Feb 05, 2026, 05:25 AM
Period
Simple
Exponential
MA5
55.18Buy
55.35Buy
MA10
55.04Buy
55.09Buy
MA20
54.94Buy
54.69Buy
MA50
52.75Buy
53.04Buy
MA100
49.96Buy
51.26Buy
MA200
49.07Buy
49.43Buy
Basilea Pharmaceutica’s (BSLN) 10-Day exponential moving average is 55.09, while Basilea Pharmaceutica’s (BSLN) share price is CHF56.5, making it a Buy.
Basilea Pharmaceutica’s (BSLN) 100-Day exponential moving average is 51.26, while Basilea Pharmaceutica’s (BSLN) share price is CHF56.5, making it a Buy.
Basilea Pharmaceutica’s (BSLN) stock price is CHF56.5 and Basilea Pharmaceutica’s (BSLN) 50-day simple moving average is 52.75, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF56.5 and Basilea Pharmaceutica’s (BSLN) 100-day simple moving average is 49.96, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF56.5 and Basilea Pharmaceutica’s (BSLN) 200-day simple moving average is 49.07, creating a Buy signal.

Basilea Pharmaceutica (BSLN) Technical Indicators

Feb 05, 2026, 05:25 AM
Name
Value
Implied Action
RSI (14)
58.10
Neutral
STOCH (9,6)
66.17
Neutral
STOCHRSI (14)
64.73
Neutral
MACD (12,26)
0.64
Buy
ADX (14)
16.06
Buy
Williams %R
-15.25
Sell
CCI (14)
93.17
Neutral
ATR (14)
1.61
-
Ultimate Oscillator
54.84
Neutral
ROC
-0.18
Sell
Basilea Pharmaceutica’s (BSLN) Relative Strength Index (RSI) is 58.10, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Trend Strength Indicator (ADX) is 16.06, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) Commodity Channel Index (CCI) is 93.17, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Price Rate of Change (ROC) is -0.18, creating a Sell signal.

FAQ

Is BSLN a Buy, Hold, or Sell?
Based on BSLN’s technical indicators, BSLN is a Strong Buy.
    What is BSLN’s RSI (14)?
    BSLN’s RSI (14) is 58.10, which suggests BSLN is a Neutral.
      What is BSLN’s MACD?
      BSLN’s MACD is 0.64, which suggests BSLN is a Buy.
        What is BSLN’s 5-day moving average?
        BSLN’s 5-day moving average is 55.18, which suggests BSLN is a Buy.
          What is BSLN’s 20-day moving average?
          BSLN 20-day moving average is 54.94, which suggests BSLN is a Buy.
            What is BSLN’s 50-day moving average?
            BSLN’s 50-day moving average is 52.75, which suggests BSLN is a Buy.
              What is BSLN’s 200-day moving average?
              BSLN’s 200-day moving average is 49.07, which suggests BSLN is a Buy.
                What is BSLN’s Williams % R (14)?
                BSLN’s Williams % R (14) is -15.25, which suggests BSLN is a Sell.
                  What is BSLN’s CCI (14)?
                  BSLN’s CCI (14) is 93.17, which suggests BSLN is a Neutral.
                    What is the share price of Basilea Pharmaceutica?